Abstract: The present invention provides a novel composition of matter useful for the treatment of neoplastic diseases. The novel composition is synergistic and comprised of galectin-3C in combination with a proteosome inhibitor, the combination having a pharmacologic activity greater than the expected additive effect of its individual components. Other embodiments of the invention provide novel synergistic compositions of galectin-3C with a proteasome inhibitor capable of reducing or overcoming resistance that develops to the proteasome inhibitor or reducing the adverse side effects from the proteasome inhibitor through increasing the therapeutic efficacy of lower doses.
Type:
Grant
Filed:
March 29, 2012
Date of Patent:
March 1, 2016
Assignees:
Texas Tech University System, MandalMed, Inc.
Inventors:
Maurizio Chiriva-Internati, Everardo Cobos, Constance John
Abstract: No effective vaccine exists for the devastating parasitic disease of Schistosomiasis. The present invention focuses on Sm-p80, a functionally important antigen of Schistosoma mansoni that plays a pivotal role in the schistosome immune evasion process. When used in a novel vaccine formulation, Sm-p80 demonstrates consistent immunogenicity, protective potential, and antifecundity effects. Two novel DNA constructs were made for immunization purposes. Sm-p80 coding sequence was cloned into VR 1020. Additionally, Sm-p80 coding sequence was cloned into pcDNA3.1 with flanking CpG motifs on each end of the Sm-p80 sequence. When used in different vaccine formulations, both of the constructs demonstrate the superior antifecundity and anti-worm effects of Sm-p80, which has great potential as an important vaccine candidate for the reduction of the morbidity associated with schistosome infection.
Type:
Grant
Filed:
June 23, 2010
Date of Patent:
February 2, 2016
Assignee:
Texas Tech University System
Inventors:
Afzal A. Siddiqui, Gul Ahmad, Weidong Zhang
Abstract: The present invention includes methods and apparatus to separate X or Y-chromosome bearing sperm cells in a population by first placing the population of sperm cells at physiological pH environment, and simultaneously contacting the population of sperm cells with one or more additional sub-environments with different pH values. The exposure allows mobile sperm cells bearing X or Y-chromosome to migrate to the different pH sub-environments, wherein each cell only exposed or come in contact with one pH sub-environment. Finally, the collecting X or Y-chromosome enriched population of sperm cells is performed.
Abstract: The present invention relates to optoelectronic device layer structures, light emitting devices, and detectors based upon heterostructures formed between hexagonal boron nitride (hNB) and III nitrides, and more particularly, to heterojunction devices capable of emitting and detecting photons in the ultraviolet (UV) and extremely ultraviolet (RUV) spectral range. The present invention also relates to neutron detectors based on epitaxially grown hBN thin films (or epitaxial layers) and hBN stacked thin films (or epitaxial layers) to satisfy the thickness required for capturing all incoming neutrons.
Abstract: A method and composition for the diagnosis of and treatment of prostate cancer including a recombinant AKAP-4 tumor-associated antigen loaded antigen presenting cell that generates an AKAP-4 specific cytotoxic T lymphocyte specific for one or more prostate cancer cells.
Abstract: This disclosure provides a method for determining if a patient is likely to, or not likely to, experience ovarian cancer utilizing SP17 as a biomarker. It also provides methods and therapies to treat patients identified as at risk for ovarian cancer or alternatively, as identified as having a poorer prognosis.
Type:
Application
Filed:
September 12, 2012
Publication date:
April 23, 2015
Applicants:
University of Southern California, Texas Tech University System
Inventors:
Wijbe Martin Kast, Maurizio Chiriva-Internati
Abstract: The present invention includes compositions and methods for the diagnosis and treatment of lung cancer with a recombinant tumor-associated antigen loaded antigen presenting cell that generates a cytotoxic T lymphocyte specific immune response to at least one of SP17, AKAP-4, or PTTG1 expressed by one or more lung cancer cells.
Abstract: The present invention includes a method for extending the shelf-life of one or more foods by exposure to one or more pulses of microwave radiation for at least seven (7) seconds. The present invention may also be used to reduce pathogenic organisms in food. The one or more foods may be packaged within a container, sealed and stored.
Type:
Grant
Filed:
August 28, 2008
Date of Patent:
February 17, 2015
Assignee:
Texas Tech University System
Inventors:
Christine Alvarado, J. Chance Brooks, Mindy M. Brashears, Todd Brashears, Gianfranco Coccoli, Pierluigi Sapelli, Mario Piazza, Stefania Franzoni, Federico Felappi, Nicola Tolettini
Abstract: A code generator and multi-core framework are executable in a computer system to implement methods as disclosed herein, including a method for the code generator to automatically generate multi-threaded source code from functional specifications, and for the multi-core framework, which is a run time component, to generate multi-threaded task object code from the multi-threaded source code and to execute the multi-threaded task object code on respective processor cores. The methods provide transparency to the programmer, and during execution, provide automatic identification of processing parallelisms. The methods implement Consume-Simplify-Produce and Normalize-Transpose-Distribute operations to reduce complex expression sets in a functional specification to simplified expression sets operable in parallel processing environments through the generated multi-threaded task object code.
Type:
Grant
Filed:
September 30, 2013
Date of Patent:
September 16, 2014
Assignee:
Texas Tech University System
Inventors:
Daniel E. Cooke, J. Nelson Rushton, Brad Nemanich
Abstract: The present invention includes a method of observing and evaluating bacterial infections within the lymph nodes of animals presented for harvest comprising: inoculating at one or more sites of an animal a known amount of a pathogen, wherein the one or more inoculation sites comprise lymph node drainage areas, and at one or more time points obtaining one or more lymph node biopsies to determine the extent of the pathogen in the lymph nodes.
Abstract: The present invention provides a novel composition of matter useful for the treatment of neoplastic diseases. The novel composition is synergistic and comprised of galectin-3C in combination with a proteosome inhibitor, the combination having a pharmacologic activity greater than the expected additive effect of its individual components. Other embodiments of the invention provide novel synergistic compositions of galectin-3C with a proteasome inhibitor capable of reducing or overcoming resistance that develops to the proteasome inhibitor or reducing the adverse side effects from the proteasome inhibitor through increasing the therapeutic efficacy of lower doses.
Type:
Application
Filed:
March 29, 2012
Publication date:
August 28, 2014
Applicant:
Texas Tech University System
Inventors:
Maurizio Chiriva-Internatí, Everardo Cobos, Constance John
Abstract: Methods and compositions are disclosed for detection of probiotic bacteria strains intentionally provided to animals comprising: providing an animal with a known amount or number of probiotic bacteria; following a pre-determined time, obtaining a biological sample suspected of comprising the inoculated probiotic bacteria from the animal; and quantitatively detecting the amount of probiotic bacteria in the biological sample.
Type:
Application
Filed:
January 14, 2014
Publication date:
July 17, 2014
Applicant:
TEXAS TECH UNIVERSITY SYSTEM
Inventors:
Mindy M. Brashears, Kendra Nightingale, Guy Loneragan, Qingli Zhang
Abstract: The present invention includes a method of delivering a therapeutic agent into and across an endothelial cell (EC) in a subject in need thereof, comprising: identifying a subject in need for treatment of a cancer in the brain; attaching to a TCR mimic an active agent to form a therapeutic agent; and administering to the subject the therapeutic agent in a pharmaceutically acceptable carrier, wherein the therapeutic agent effectively crosses the blood-central nervous system microvascular barrier.
Abstract: The present invention includes a method of delivering a therapeutic agent into and across an endothelial cell (EC) in a subject in need thereof, comprising: attaching to a T Cell receptor mimic (TCR mimic) an active agent to form a therapeutic agent; and administering to the subject the therapeutic agent in a pharmaceutically acceptable carrier, wherein the therapeutic agent effectively crosses the EC microvascular barrier. Furthermore, the present invention relates to methods of treating diseases (particularly neuronal diseases) or conditions comprising identifying a subject in need of such a treatment and administering to said subject a composition comprising a TCR mimic conjugated to an active agent.
Abstract: A code generator and multi-core framework are executable in a computer system to implement methods as disclosed herein, including a method for the code generator to automatically generate multi-threaded source code from functional specifications, and for the multi-core framework, which is a run time component, to generate multi-threaded task object code from the multi-threaded source code and to execute the multi-threaded task object code on respective processor cores. The methods provide transparency to the programmer, and during execution, provide automatic identification of processing parallelisms. The methods implement Consume-Simplify-Produce and Normalize-Transpose-Distribute operations to reduce complex expression sets in a functional specification to simplified expression sets operable in parallel processing environments through the generated multi-threaded task object code.
Type:
Application
Filed:
September 30, 2013
Publication date:
April 17, 2014
Applicant:
Texas Tech University System
Inventors:
Daniel E. Cooke, J. Nelson Rushton, Brad Nemanich
Abstract: The present invention includes compositions, methods of making and using the compositions for modulating the immune response in a subject by providing a vaccine composition having a pollen/spore disposed in a pharmaceutical carrier for delivery to a subject, wherein the pollen/spore comprises multiple pores that connect an outer surface of the pollen/spore to an inner cavity and one or more antigens disposed on the outer surface, in the inner cavity, in the multiple pores, or a combination thereof, wherein the one or more antigens modulate an immune responses in the subject.
Type:
Application
Filed:
October 14, 2013
Publication date:
April 17, 2014
Applicant:
Texas Tech University System
Inventors:
Harvinder S. Gill, Shashwati Atwe, Yunzhe Ma
Abstract: A method of manufacturing a biodiesel fuel that comprises mixing a co-solvent, a first reactant and a second reactant together in a mixing chamber to form a homogeneous solution. The first reactant and the second reactant are substantially immiscible with each other in the absence of the co-solvent. The first reactant is one of an alcohol or an oil, and the second reactant is the other of the oil or the alcohol. Method also comprises transferring the homogeneous solution into a transesterification reaction vessel.
Abstract: A system, method and apparatus securely save data by receiving a file from a user device, wherein the file contains an encrypted data and has a file name. The encrypted data is then split into two or more encrypted data chunks having a specified size. A chunk number is assigned to each of the two or more encrypted data chunks. Each of the two or more encrypted data chunks is saved in a chunk file having a chunk file name comprising a combination of the file name and the chunk number. Each chunk file name is then encrypted, and each chunk file having the encrypted chunk file name is sent to the data storage. The process is essentially reversed to retrieve the data.
Type:
Application
Filed:
September 13, 2013
Publication date:
March 20, 2014
Applicant:
Texas Tech University System
Inventors:
Timothy E. Roden, Mathew Gray, Andy Wallace
Abstract: The present invention provides a method and compositions of regulating plant development and secondary metabolite biosynthesis by providing one or more plant cells; providing a small interfering RNAs (ta-siRNAs) to the one or more plant cells; targeting a transcription factor to affect the plant development and/or secondary metabolite biosynthesis.
Abstract: The present invention provides a method of optimizing the placement of fractures along deviated wellbores by identifying at least two parallel lateral wellbores in a subterranean formation comprising at least a first wellbore and a second wellbore; introducing a first fracture and a second fracture in the first wellbore; introducing a third fracture in the second wellbore between the first fracture and the second fracture, wherein the third fracture extends to an intermediate area between the first two fractures and alters the stress field in that region; and forming one or more complex fractures extending from the first fracture, the second fracture, the third fracture or a combination thereof to form a complex fracture network.
Type:
Application
Filed:
August 20, 2013
Publication date:
February 20, 2014
Applicant:
Texas Tech University System
Inventors:
Mohamed Soliman, Mehdi Rafiee, Elias Pirayesh